Mespere Lifesciences Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Mespere Lifesciences General Information

Description

Developer of a medical technology platform. The company's software is based upon near infrared spectroscopy for monitoring of the hemodynamics within central venous blood vessels.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare
Social/Platform Software
Primary Office
  • 180 Frobisher Drive
  • Suite 1C
  • Waterloo, Ontario N2V 2A2
  • Canada
+1 (519) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Mespere Lifesciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 12-Dec-2012 Completed Startup
1. Grant 19-Aug-2010 00000 Completed Startup
To view Mespere Lifesciences’s complete valuation and funding history, request access »

Mespere Lifesciences Executive Team (1)

Name Title Board Seat Contact Info
Xuefeng Cheng Ph.D Chief Executive Officer
To view Mespere Lifesciences’s complete executive team members history, request access »

Mespere Lifesciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mespere Lifesciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Accelerator Centre Accelerator/Incubator 000 0000 000000 0
To view Mespere Lifesciences’s complete investors history, request access »